Quadrise Fuels International (8QF) Q2 2026 Earnings Report

The call conveys cautious optimism: multiple near-term operational positives (MSC/Cargill trial close, OCP traction, Valkor payments and pilot plan, USD 4.0M cash + expected receipts, strengthened team and R&D collaborations) signal momentum toward commercialization. However, material execution risks remain—legal/commercial finalization for the MSC trilateral agreement, Valkor pilot/sample delays, feedstock scaling complexity, regulatory/IMO timing uncertainty, and increased cash burn. Management presents these as manageable pragmatic issues rather than fundamental technology failures, resulting in a constructive but cautious outlook.

The call set out clear near‑term milestones and cash guidance: cash at 31 Dec was $4.0m, historical cash burn ~$3.0m/yr (recently +10–15% → ~ $3.3–3.45m/yr), and management expects ~USD 950k–1.0m from Valkor (a $300k installment due end of month and ~$650k due end of year), plus small grant receipts (c.$12k recognized in the period; ~ $50k total grant cash); tax losses stand at ~£68m. Operational metrics and timing include two MSC/Cargill trials (MSAR and bioMSAR) now close to signature, an OCP trial of ~15–30 days depending on kiln size, Valkor pilot runs producing samples with pilot plant installation targeted in Q3 and full plant operational in Q4 and Quadrise’s unit shipping in Q2. Scale‑up planning covers a gross shortlist of ~25 refineries, an Antwerp branch filed, priority bunkering hubs (Singapore, N. Europe, Med, Americas), ISCC audit post‑commissioning, and technology constraints (MSAR ~30% water vs bioMSAR ~10% water); the company is also in an EU digital‑twin project with ~18 partners (modelling 4 existing + 4 new‑build vessel types) and has added hires (Matthew Hyde, 30+ years; Michael Covington), with 45 investor questions logged.